|
Market Closed -
Australian S.E.
01:10:13 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 2.740 AUD | -0.36% |
|
-1.79% | +6.20% |
| Market Cap | 148M 104M 93.38M 86.15M 77.96M 146M 9.93B 1.03B 410M 5.2B 391M 383M 16.46B | P/E 2024 |
12.7x | P/E 2025 | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 115M 80.91M 72.47M 66.86M 60.5M 113M 7.71B 798M 318M 4.03B 304M 297M 12.77B | EV / Sales 2024 |
1.05x | EV / Sales 2025 | 1.16x |
| Free-Float |
21.93% | Yield 2024 |
5% | Yield 2025 | 5.43% |
| 1 day | -0.36% | ||
| 1 week | -1.79% | ||
| Current month | -0.36% | ||
| 3 months | +9.60% | ||
| 6 months | +6.61% | ||
| Current year | +6.20% |
| 1 week | 2.74 |  | 2.8 |
| 1 month | 2.7 | | 2.9 |
| Current year | 2.27 | | 2.9 |
| 1 year | 2.27 | | 2.9 |
| 3 years | 1.6 | | 2.9 |
| 5 years | 1.35 | | 2.9 |
| 10 years | 0.54 | | 2.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew OKeefe
CEO | Chief Executive Officer | - | 2016-12-31 |
Chin Leng Khoo
DFI | Director of Finance/CFO | - | 2009-10-24 |
Shaun Rutherford
SAM | Sales & Marketing | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Townsing
CHM | Chairman | 70 | 2016-10-12 |
Andrew OKeefe
BRD | Director/Board Member | - | 2016-12-31 |
Jack Teoh
BRD | Director/Board Member | - | 2022-09-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/2/26 | Buy | Director | 1,000 | 0.0018% | ||
| 9/1/26 | Sell | Chairman | -30,000 | 0.0552% | ||
| 5/29/26 | Sell | Chairman | -29,947 | 0.0551% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -1.79% | +16.10% | +52.22% | 105M | |
| +6.63% | +8.10% | +67.50% | +145.20% | 1,148B | |
| +1.53% | +6.76% | +47.22% | +89.01% | 652B | |
| +1.68% | +2.10% | +27.80% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -2.37% | +68.14% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +5.11% | +57.74% | +76.14% | 244B | |
| +4.03% | +7.84% | +40.49% | +116.14% | 197B | |
| Average | +2.98% | +1.10% | +41.79% | +78.62% | 403.73B | |
| Weighted average by Cap. | +3.64% | +1.50% | +49.58% | +95.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 79.5M 55.95M 50.12M 46.24M 41.84M 78.24M 5.33B 552M 220M 2.79B 210M 206M 8.83B | 93.27M 65.64M 58.8M 54.24M 49.09M 91.79M 6.25B 647M 258M 3.27B 246M 241M 10.36B |
| Net income | 8.78M 6.18M 5.54M 5.11M 4.62M 8.64M 589M 60.95M 24.31M 308M 23.2M 22.71M 976M | 10.44M 7.34M 6.58M 6.07M 5.49M 10.27M 699M 72.4M 28.88M 366M 27.56M 26.97M 1.16B |
| Net Debt | -28.08M -19.76M -17.7M -16.33M -14.78M -27.64M -1.88B -195M -77.74M -985M -74.18M -72.6M -3.12B | -33.17M -23.35M -20.91M -19.29M -17.46M -32.64M -2.22B -230M -91.82M -1.16B -87.61M -85.75M -3.68B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | A$2.740 | -0.36% | 23,031 |
| 26-10-28 | A$2.750 | -1.79% | 210 |
| 26-10-27 | A$2.800 | 0.00% | 50,878 |
| 26-10-26 | A$2.800 | 0.00% | 4,232 |
| 26-10-23 | A$2.800 | +1.08% | 19,930 |
- Stock Market
- Stocks
- VLS Stock
Select your edition
All financial news and data tailored to specific country editions
